Cargando…
No increased risk of infant hypospadias after maternal use of loratadine in early pregnancy
The original report published in 2001 on a possible association between maternal use of loratadine and an increased risk of infant hypospadias, based on data in the Swedish Medical Birth Register 1995-2001, has been followed up by continued surveillance in the same register. The original “signal” wa...
Autores principales: | Källén, Bengt, Olausson, Petra Otterblad |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475429/ https://www.ncbi.nlm.nih.gov/pubmed/16761079 |
Ejemplares similares
-
Maternal use of Loratadine during pregnancy and risk of hypospadias in offspring
por: Pedersen, Lars, et al.
Publicado: (2006) -
Maternal Hypothyroidism in Early Pregnancy and Infant Structural Congenital Malformations
por: Källén, Bengt, et al.
Publicado: (2014) -
Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy in comparison with unvaccinated controls
por: Sabharwal, Vishakha, et al.
Publicado: (2023) -
Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group study
por: Peters, A M, et al.
Publicado: (2006) -
Maternal SARS-CoV-2 infection during pregnancy: possible impact on the infant
por: Morhart, Patrick, et al.
Publicado: (2021)